Adar1 Capital Management, LLC Aldeyra Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 647,960 shares of ALDX stock, worth $4.21 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
647,960
Previous 302,212
114.41%
Holding current value
$4.21 Million
Previous $1.63 Billion
98.49%
% of portfolio
0.65%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding ALDX
# of Institutions
130Shares Held
38MCall Options Held
764KPut Options Held
544K-
Perceptive Advisors LLC New York, NY9.28MShares$60.2 Million1.54% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$35.5 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$24.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$23.5 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.47MShares$9.53 Million0.17% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $379M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...